These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 2606139)

  • 1. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
    Jarvis GA; Griffiss JM
    J Immunol; 1991 Sep; 147(6):1962-7. PubMed ID: 1909736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
    Lohse S; Peipp M; Beyer T; Valerius T; Dechant M
    Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):303-12. PubMed ID: 20508996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal human sera contain antibodies directed at Fab of IgA.
    Jackson S; Montgomery RI; Mestecky J; Czerkinsky C
    J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.
    Hughes-Jones NC; Gorick BD; Howard JC
    Eur J Immunol; 1983 Aug; 13(8):635-41. PubMed ID: 6603980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation is not required for IgG-mediated suppression of the antibody response.
    Heyman B; Wiersma E; Nose M
    Eur J Immunol; 1988 Nov; 18(11):1739-43. PubMed ID: 3060362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effector mechanisms of IgA].
    Vaerman JP
    Ann Biol Clin (Paris); 1984; 42(1):61-70. PubMed ID: 6375472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
    Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
    Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).
    Boackle RJ; Nguyen QL; Leite RS; Yang X; Vesely J
    Mol Immunol; 2006 Feb; 43(3):236-45. PubMed ID: 16199260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the biological functions of monoclonal immunoglobulins and their fragments.
    Kraj M; Cieśluk S; Rezmer M; Bragiel I; Snigurowicz J
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):297-312. PubMed ID: 7447642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
    Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
    Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
    Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.